Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
Misschien is de omzet zo slecht dat Sopheon geen update aandurft????? Kan ook zijn dat ze zoveel omzet draaien dat ze nog niet klaar zijn met pegels tellen. Gr Arie de Beuker
arie, moet een beursgenoteerd bedrijf dat niet melden dan?
Jazeker, maar het was humoristisch bedoeld.
verwacht van 2020 niet veel, met al die virus en brexit ellende, voordat allemaal gesetteld is, zitten we eind 2022.
8,70 jazeker leven we nog, en we geven ook niets uit door Corona:-)))
volume ruim 24000, al de aan/verkoop tijden staan door elkaar heen, die marketmaker maakt er weer een warboel van.
De koers/volume stijging kreeg nog geen vervolg de afgelopen dagen. Dan deze week maar een update? Gr Arie de Beuker
Trading Update Sopheon, the international provider of software and services for Enterprise Innovation Management solutions, provides the following trading update for the year ended 31 December 2020. As in prior years, the final quarter was the strongest of the year for the Group, and in fact stronger than 2019, despite the resurgence of Covid concerns globally. We are pleased to report ongoing commercial traction and material progress in two strategic areas of focus: migration to a Software as a Service (“SaaS”) recurring revenue model – giving both enhanced revenue visibility to future periods and improved quality of earnings – and landing large enterprise class contracts with major companies. Total contract value (“TCV”) of signed SaaS business grew 274% year on year, due to rapid adoption by our sales teams of the SaaS model for new customers, as well as converting some existing perpetual customers. Annual Recurring Revenue (“ARR”) gross retention for the year remained respectable, at 91.5% (2019: 94.2%) but this represented greater than normal attrition, which is unsurprising given the challenging market conditions for some customers last year. Overall, the TCV of all sales bookings increased by 23% year on year, but the shift of emphasis from perpetual to multi-year SaaS means that most of this revenue will be recognized over time, rather than in the year of sale. New wins included global brands such as DuPont and LG, alongside previously announced Mondelez and Orion. Six of our new customers had initial deal value at $1m or more, compared to just one in 2019, underlining material traction with enterprise sales even in these difficult times. We expect that revenue for the year ended 31 December 2020 will be approximately $30m, in line with our 2019 performance. ARR is expected to rise to $18m (2019: $15.9m). This, coupled with a substantial order book of services, means that revenue visibility1 for 2021 is already at $22m (2019: $18.9m) giving cause for optimism regarding the year ahead. Adjusted EBITDA is expected to be in the region of $5.6m (2019: $6.4m). Net cash on 31 December 2020 was $21.6m (2019: $19.4m), demonstrating the cash generative nature of the business as well as the robust balance sheet. As noted previously, billing seasonality means that this number should rise in the early part of 2021. In addition, costs reflect initial investments in a native cloud platform to enable new SaaS products, that will take us into new market segments. This was in parallel with further investments in our enterprise Accolade platform. These initiatives will continue in 2021. Financial expectations noted above are preliminary, and subject to year-end financial close and audit review processes. In line with our normal reporting schedule, Sopheon plans to issue its results for the year ended 31 December 2020 on 24 March 2021.Sopheon’s Chairman, Barry Mence said: “I’m very proud that Sopheon has been able to match prior year revenue and grow total sales bookings in such a difficult global climate. We’ve done this while simultaneously embarking on a migration of our business from up-front perpetual license sales to a SaaS subscription model – leading to a solid increase in recurring revenues, and providing greater visibility to future years. We believe we have a substantial opportunity ahead of us, and our strong balance sheet gives us the confidence to maintain ambitious investment plans through the pandemic and beyond.” For Further Information Contact: Barry Mence, Chairman Arif Karimjee, CFO Sopheon plc + 44 (0) 1276 919 560www.sopheon.com/trading-update-01252021/ Bertus S.
Gezien de algehele malaise in het zakenwereldje mogen we niet ontevreden zijn met deze update, en nu maar hopen op een beter 2021!
Ziet er zeer goed uit! Deze zin ook: In addition, costs reflect initial investments in a native cloud platform to enable new SaaS products, that will take us into new market segments. Groet ABC
Vind ik ook ...en Finncap ook So consistent for FY20 and so good for FY21 Sopheon’s trading update for 4Q and FY20 demonstrates typical year-end strength to finish off a stable FY20 despite COVID effects which had led to suspension of forecasts. With the increased proportion of SaaS new contract wins, ARR grew 13% to $18m (FY19: $15.9m) while total TCV won in the year (SaaS and licences) grew 23%, demonstrating very strong ongoing order momentum. While FY20 was affected by COVID in delaying customer decision making, and increasing gross churn from 5.8% to 8.5% (still a low level which listed peers can only dream of), nevertheless revenue remained robust at $30m (FY19: $30m), and EBITDA laudable at $5.6m ($6.4m), accommodating both the planned increase in investment and protracted SaaS revenue recognition. Net cash at year end of $21.6m ($19.4m) continues to enable the board’s positive strategic choices including increased R&D. Most importantly, as the business transitions from licences to a licence / subscription mix, total orders were are at record levels including SaaS TCV of orders in the period +274%, leading visibility of full-year revenue for FY21 to a record $22m so early in the year, +16% vs January 2020 ($18.9m). We look forward to finals for more detail to re-introduce FY21 forecasts, with our 1200p reiterated with the evidence of both order strength and a return to normality. 1: Deal sizes: the growth in TCV of 23% includes SaaS TCV growth of 274% but also a higher number of new customers with initial deal values >$1m – six during FY20, compared with one during FY19, demonstrating product credibility and momentum. New customers included global brands such as Mondelez and Orion, as previously disclosed, and also DuPont and LG. 2: The metrics for the company have always been afforded reassurance by the visibility of revenue, including services. Visibility currently stands at $22m for FY21, including the benefit of ARR of $18m; and we expect the transition of the focus for KPIs (and ultimately valuation) to ARR and TCV. The TCV growth, which comprises the total value of licences and contracted maintenance fees & professional services as well as multi-year SaaS contracts, represents a measure of momentum even during transition: 23% growth is very positive and we look forward to detail. 3:We restore FY20 expectations with guidance of $30m revenue, $5.6m adj EBITDA, and $21.6m cash (no debt) showing robust performance in the face of the pandemic. The stock is trading on 3.5x FY20 EV / Sales in a year of suppressed sales. Price 865.0p Target price 1,200.0p Upside 39%www.finncap.com/research-portal?#/por...
Nou op naar die 12 pond dan maar;-))
Valt niet tegen, maar een lauwe reaktie van de koers op de cijfers. Gr Arie de Beuker
Soof heeft wel vaker een aardige update gegeven, dat we dachten dit moet toch wat met de koers gaan doen, maar dan zag je juist het tegenover gestelde gebeuren, ben al lang blij dat ze met deze update voor de dag kwamen, en gezien de toekomst zal die koers er wel achter aan hobbelen.
Barry Mence, de voorzitter van Sopheon, zei: "Ik ben erg trots dat Sopheon in staat is geweest om de inkomsten van voorgaande jaren te evenaren en de totale verkoopboekingen te laten groeien in zo'n moeilijk mondiaal klimaat. We hebben dit gedaan terwijl we tegelijkertijd begonnen met een migratie van ons bedrijf van doorlopende verkoop van licenties vooraf aan een SaaS-abonnementsmodel, wat leidt tot een stevige stijging van de terugkerende inkomsten en meer zichtbaarheid voor toekomstige jaren. We denken dat we een aanzienlijke kans voor ons hebben, en onze sterke balans geeft ons het vertrouwen om handhaven van ambitieuze investeringsplannen tijdens de pandemie en daarna. " Dus op naar 2021 en 2022, en anders zal ik het met mijn aow moeten doen;-))
Toch wel een interessante quote volgens mij Sopheon’s Chairman, Barry Mence said: “...............We believe we have a substantial opportunity ahead of us, and our strong balance sheet gives us the confidence to maintain ambitious investment plans through the pandemic and beyond.”
Hoelang hebben ze het al over een overname, fusie of zoiets? Maar ik laat me graag verrassen hoor. Gr Arie de Beuker
Sopheon and Australian Partner Prodex Systems Extend CPG Innovation Leadership with the J. R. Simplot Company Contract Sopheon and Prodex Systems team up to enable innovation governance and portfolio prioritization for the global food and agribusiness firm Sopheon, an international global leader in enterprise innovation management solutions, and its consulting partner Prodex Systems Australasia will automate and accelerate innovation at the J. R. Simplot Company, the global food and agribusiness firm. Sopheon and Prodex will collaborate to deploy Sopheon’s Accolade® platform at Simplot, beginning with its Simplot Australia division. The goal of Simplot’s deployment is to reduce innovation risk and increase the likelihood of new product successes via the adoption of Sopheon Stage-Gate® best practices.According to Angeline Achariya, Executive Director of Innovation & Growth at Simplot Australia Proprietary Ltd., “At Simplot, we are committed to a strategy to accelerate growth in EBIT through significant increases in contribution from New Product Introductions. Simplot undertook a rigorous search for the appropriate software platform and partner to support ambitious growth goals.” The first phase of deployment will provide full enterprise capabilities in innovation governance. Simplot selected Sopheon’s software platform for its advanced capabilities in innovation planning and roadmapping, and the ability to align targeted ideation campaigns with strategic planning gaps. These foundational capabilities will streamline Simplot’s innovation processes and drive the adoption of scalable, enterprise-wide process standards, improving efficiency, time to market, and portfolio success.Sopheon CEO, Andy Michuda, added: “We are excited to include Simplot in our growing Sopheon family of food and agribusiness clients, and are delighted to team with our long-time partner Prodex to enable Simplot’s global innovation transformation. This contract aligns well with Sopheon’s objective to expand our user base in the Australasian region.” Prodex Systems Managing Director, Gerard Ryan, added: “Prodex has been a supplier to Simplot Australia for over 10 years. Sopheon has deep domain expertise, and a great depth of configurability in the Accolade software, a common requirement of large, global consumer goods firms. We look forward to growing our partnership with Simplot, and to helping them achieve their impressive growth goals for many years to come.” For Further Information Contact: Barry Mence, Chairman Arif Karimjee, CFO Sopheon plc + 44 (0) 1276 919 560www.sopheon.com/sopheon-and-australia... Bertus S.
Aantal posts per pagina:
20
50
100
Direct naar Forum
-- Selecteer een forum --
Koffiekamer
Belastingzaken
Beleggingsfondsen
Beursspel
BioPharma
Daytraders
Garantieproducten
Opties
Technische Analyse
Technische Analyse Software
Vastgoed
Warrants
10 van Tak
4Energy Invest
Aalberts
AB InBev
Abionyx Pharma
Ablynx
ABN AMRO
ABO-Group
Acacia Pharma
Accell Group
Accentis
Accsys Technologies
ACCSYS TECHNOLOGIES PLC
Ackermans & van Haaren
ADMA Biologics
Adomos
AdUX
Adyen
Aedifica
Aegon
AFC Ajax
Affimed NV
ageas
Agfa-Gevaert
Ahold
Air France - KLM
Airspray
Akka Technologies
AkzoNobel
Alfen
Allfunds Group
Allfunds Group
Almunda Professionals (vh Novisource)
Alpha Pro Tech
Alphabet Inc.
Altice
Alumexx ((Voorheen Phelix (voorheen Inverko))
AM
Amarin Corporation
Amerikaanse aandelen
AMG
AMS
Amsterdam Commodities
AMT Holding
Anavex Life Sciences Corp
Antonov
Aperam
Apollo Alternative Assets
Apple
Arcadis
Arcelor Mittal
Archos
Arcona Property Fund
arGEN-X
Aroundtown SA
Arrowhead Research
Ascencio
ASIT biotech
ASMI
ASML
ASR Nederland
ATAI Life Sciences
Atenor Group
Athlon Group
Atrium European Real Estate
Auplata
Avantium
Axsome Therapeutics
Azelis Group
Azerion
B&S Group
Baan
Ballast Nedam
BALTA GROUP N.V.
BAM Groep
Banco de Sabadell
Banimmo A
Barco
Barrick Gold
BASF SE
Basic-Fit
Basilix
Batenburg Beheer
BE Semiconductor
Beaulieulaan
Befimmo
Bekaert
Belgische aandelen
Beluga
Beter Bed
Bever
Binck
Biocartis
Biophytis
Biosynex
Biotalys
Bitcoin en andere cryptocurrencies
bluebird bio
Blydenstijn-Willink
BMW
BNP Paribas S.A.
Boeing Company
Bols (Lucas Bols N.V.)
Bone Therapeutics
Borr Drilling
Boskalis
BP PLC
bpost
Brand Funding
Brederode
Brill
Bristol-Myers Squibb
Brunel
C/Tac
Campine
Canadese aandelen
Care Property Invest
Carmila
Carrefour
Cate, ten
CECONOMY
Celyad
CFD's
CFE
CGG
Chinese aandelen
Cibox Interactive
Citygroup
Claranova
CM.com
Co.Br.Ha.
Coca-Cola European Partners
Cofinimmo
Cognosec
Colruyt
Commerzbank
Compagnie des Alpes
Compagnie du Bois Sauvage
Connect Group
Continental AG
Corbion
Core Labs
Corporate Express
Corus
Crescent (voorheen Option)
Crown van Gelder
Crucell
CTP
Curetis
CV-meter
Cyber Security 1 AB
Cybergun
D'Ieteren
D.E Master Blenders 1753
Deceuninck
Delta Lloyd
DEME
Deutsche Cannabis
DEUTSCHE POST AG
Dexia
DGB Group
DIA
Diegem Kennedy
Distri-Land Certificate
DNC
Dockwise
DPA Flex Group
Draka Holding
DSC2
DSM
Duitse aandelen
Dutch Star Companies ONE
Duurzaam Beleggen
DVRG
Ease2pay
Ebusco
Eckert-Ziegler
Econocom Group
Econosto
Edelmetalen
Ekopak
Elastic N.V.
Elia
Endemol
Energie
Energiekontor
Engie
Envipco
Erasmus Beursspel
Eriks
Esperite (voorheen Cryo Save)
EUR/USD
Eurobio
Eurocastle
Eurocommercial Properties
Euronav
Euronext
Euronext
Euronext.liffe Optiecompetitie
Europcar Mobility Group
Europlasma
EVC
EVS Broadcast Equipment
Exact
Exmar
Exor
Facebook
Fagron
Fastned
Fingerprint Cards AB
First Solar Inc
FlatexDeGiro
Floridienne
Flow Traders
Fluxys Belgium D
FNG (voorheen DICO International)
Fondsmanager Gezocht
ForFarmers
Fountain
Frans Maas
Franse aandelen
FuelCell Energy
Fugro
Futures
FX, Forex, foreign exchange market, valutamarkt
Galapagos
Gamma
Gaussin
GBL
Gemalto
General Electric
Genfit
Genmab
GeoJunxion
Getronics
Gilead Sciences
Gimv
Global Graphics
Goud
GrandVision
Great Panther Mining
Greenyard
Grolsch
Grondstoffen
Grontmij
Guru
Hagemeyer
HAL
Hamon Groep
Hedge funds: Haaien of helden?
Heijmans
Heineken
Hello Fresh
HES Beheer
Hitt
Holland Colours
Homburg Invest
Home Invest Belgium
Hoop Effektenbank, v.d.
Hunter Douglas
Hydratec Industries (v/h Nyloplast)
HyGear (NPEX effectenbeurs)
HYLORIS
Hypotheken
IBA
ICT Automatisering
Iep Invest (voorheen Punch International)
Ierse aandelen
IEX Group
IEX.nl Sparen
IMCD
Immo Moury
Immobel
Imtech
ING Groep
Innoconcepts
InPost
Insmed Incorporated (INSM)
IntegraGen
Intel
Intertrust
Intervest Offices & Warehouses
Intrasense
InVivo Therapeutics Holdings Corp (NVIV)
Isotis
JDE PEET'S
Jensen-Group
Jetix Europe
Johnson & Johnson
Just Eat Takeaway
Kardan
Kas Bank
KBC Ancora
KBC Groep
Kendrion
Keyware Technologies
Kiadis Pharma
Kinepolis Group
KKO International
Klépierre
KPN
KPNQwest
KUKA AG
La Jolla Pharmaceutical
Lavide Holding (voorheen Qurius)
LBC
LBI International
Leasinvest
Logica
Lotus Bakeries
Macintosh Retail Group
Majorel
Marel
Mastrad
Materialise NV
McGregor
MDxHealth
Mediq
Melexis
Merus Labs International
Merus NV
Microsoft
Miko
Mithra Pharmaceuticals
Montea
Moolen, van der
Mopoli
Morefield Group
Mota-Engil Africa
MotorK
Moury Construct
MTY Holdings (voorheen Alanheri)
Nationale Bank van België
Nationale Nederlanden
NBZ
Nedap
Nedfield
Nedschroef
Nedsense Enterpr
Nel ASA
Neoen SA
Neopost
Neovacs
NEPI Rockcastle
Netflix
New Sources Energy
Neways Electronics
NewTree
NexTech AR Solutions
NIBC
Nieuwe Steen Investments
Nintendo
Nokia
Nokia OYJ
Nokia Oyj
Novacyt
NOVO-NORDISK AS
NPEX
NR21
Numico
Nutreco
Nvidia
NWE Nederlandse AM Hypotheek Bank
NX Filtration
NXP Semiconductors NV
Nyrstar
Nyxoah
Océ
OCI
Octoplus
Oil States International
Onconova Therapeutics
Ontex
Onward Medical
Onxeo SA
OpenTV
OpGen
Opinies - Tilburg Trading Club
Opportunty Investment Management
Orange Belgium
Oranjewoud
Ordina Beheer
Oud ForFarmers
Oxurion (vh ThromboGenics)
P&O Nedlloyd
PAVmed
Payton Planar Magnetics
Perpetuals, Steepeners
Pershing Square Holdings Ltd
Personalized Nursing Services
Pfizer
Pharco
Pharming
Pharnext
Philips
Picanol
Pieris Pharmaceuticals
Plug Power
Politiek
Porceleyne Fles
Portugese aandelen
PostNL
Priority Telecom
Prologis Euro Prop
ProQR Therapeutics
PROSIEBENSAT.1 MEDIA SE
Prosus
Proximus
Qrf
Qualcomm
Quest For Growth
Rabobank Certificaat
Randstad
Range Beleggen
Recticel
Reed Elsevier
Reesink
Refresco Gerber
Reibel
Relief therapeutics
Renewi
Rente en valuta
Resilux
Retail Estates
RoodMicrotec
Roularta Media
Royal Bank Of Scotland
Royal Dutch Shell
RTL Group
RTL Group
S&P 500
Samas Groep
Sapec
SBM Offshore
Scandinavische (Noorse, Zweedse, Deense, Finse) aandelen
Schuitema
Seagull
Sequana Medical
Shurgard
Siemens Gamesa
Sif Holding
Signify
Simac
Sioen Industries
Sipef
Sligro Food Group
SMA Solar technology
Smartphoto Group
Smit Internationale
Snowworld
SNS Fundcoach Beleggingsfondsen Competitie
SNS Reaal
SNS Small & Midcap Competitie
Sofina
Softimat
Solocal Group
Solvac
Solvay
Sopheon
Spadel
Sparen voor later
Spectra7 Microsystems
Spotify
Spyker N.V.
Stellantis
Stellantis
Stern
Stork
Sucraf A en B
Sunrun
Super de Boer
SVK (Scheerders van Kerchove)
Syensqo
Systeem Trading
Taiwan Semiconductor Manufacturing Company (TSMC)
Technicolor
Tele Atlas
Telegraaf Media
Telenet Groep Holding
Tencent Holdings Ltd
Tesla Motors Inc.
Tessenderlo Group
Tetragon Financial Group
Teva Pharmaceutical Industries
Texaf
Theon International
TherapeuticsMD
Thunderbird Resorts
TIE
Tigenix
Tikkurila
TINC
TITAN CEMENT INTERNATIONAL
TKH Group
TMC
TNT Express
TomTom
Transocean
Trigano
Tubize
Turbo's
Twilio
UCB
Umicore
Unibail-Rodamco
Unifiedpost
Unilever
Unilever
uniQure
Unit 4 Agresso
Univar
Universal Music Group
USG People
Vallourec
Value8
Value8 Cum Pref
Van de Velde
Van Lanschot
Vastned
Vastned Retail Belgium
Vedior
VendexKBB
VEON
Vermogensbeheer
Versatel
VESTAS WIND SYSTEMS
VGP
Via Net.Works
Viohalco
Vivendi
Vivoryon Therapeutics
VNU
VolkerWessels
Volkswagen
Volta Finance
Vonovia
Vopak
Warehouses
Wave Life Sciences Ltd
Wavin
WDP
Wegener
Weibo Corp
Wereldhave
Wereldhave Belgium
Wessanen
What's Cooking
Wolters Kluwer
X-FAB
Xebec
Xeikon
Xior
Yatra Capital Limited
Zalando
Zenitel
Zénobe Gramme
Ziggo
Zilver - Silver World Spot (USD)
Indices
AEX
872,14
+0,65%
EUR/USD
1,0694
+0,39%
FTSE 100
8.042,25
+0,23%
Germany40^
18.077,40
+1,21%
Gold spot
2.328,37
+0,05%
NY-Nasdaq Composite
15.451,31
+1,11%
Stijgers
Dalers